Nitrate Administration Increases Blood Flow in Dysfunctional but Viable Myocardium, Leading to Improved Assessment of Myocardial Viability: A PET Study
Riemer H.J.A. Slart1,
Ali Agool1,
Dirk J. van Veldhuisen2,
Rudi A. Dierckx1 and
Jeroen J. Bax3
1 Department of Nuclear Medicine and Molecular Imaging, University Medical Center, Groningen, The Netherlands; 2 Department of Cardiology, University Medical Center, Groningen, The Netherlands; and 3 Department of Cardiology, University Medical Center, Leiden, The Netherlands

View larger version (13K):
[in a new window]
|
FIGURE 1. 13N-Ammonia flow parameters in 18F-FDG viable and nonviable segments. Baseline = 13N-ammonia baseline flow; NTG = 13N-ammonia-NTG. *Not statistically significant, 13N-ammonia baseline flow in viable segments vs. in nonviable segments. #P = 0.009, 13N-ammonia nitrate-enhanced flow in viable segments vs. in nonviable segments.
|
|

View larger version (9K):
[in a new window]
|
FIGURE 2. ROC curves of 13N-ammonia baseline, 13N-ammonia-NTG, and ratio of 13N-ammonia-NTG to 13N-ammonia baseline to detect viability on 18F-FDG PET in all dysfunctional segments. Ratio = ratio of 13N-ammonia-NTG to 13N-ammonia baseline; NTG = 13N-ammonia-NTG; rest = 13N-ammonia baseline.
|
|

View larger version (9K):
[in a new window]
|
FIGURE 3. ROC curves of 13N-ammonia baseline, 13N-ammonia-NTG, and ratio of 13N-ammonia-NTG to 13N-ammonia baseline to detect viability on 18F-FDG PET in akinetic or dyskinetic segments. Ratio = ratio of 13N-ammonia-NTG to 13N-ammonia baseline; NTG = 13N-ammonia-NTG; rest = 13N-ammonia baseline.
|
|
Copyright © 2006 by the Society of Nuclear Medicine.